Ono Pharmaceutical (OTC:OPHLF) Stock, Quote.Headers.trade-ideas

Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

ONO PHARMACEUTICAL by Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co Ltd

Merus Stock: Rally Seems Overdone

Ono Pharmaceutical GAAP EPS of ¥229.06, revenue of ¥389.91B

Ono Pharmaceutical reports FY results

Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript

ONO Pharmaceutical Co (JP:4528) has released an update. Ono Pharmaceutical Co., Ltd. is prioritizing corporate governance by increasing management ...

Ono Pharmaceutical Advances Governance and Diversity

In a report released yesterday, Stephen Barker from Jefferies maintained a Hold rating on ONO Pharmaceutical Co (OPHLF – Research Report), with a p...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Ono Pharmaceutical

Ono Pharmaceutical (OPHLF) Forecast

Ono Pharmaceutical (OTC:OPHLF) Stock, Quote.Headers.trade-ideas